Core Viewpoint - YS Biopharma Co., Ltd. is changing its legal name to LakeShore Biopharma Co., Ltd. to enhance its global market positioning and brand image [1] Group 1: Company Name Change - The name change to LakeShore Biopharma is part of the company's strategy to expand its market reach [1] - The trading symbol will change from "YS" to "LSB" and from "YSBPW" to "LSBPW" effective May 28, 2024 [1] - The name change will not affect shareholders' rights or the company's operations and financial position [1] Group 2: Company Overview - LakeShore Biopharma focuses on discovering, developing, manufacturing, and delivering vaccines and therapeutic biologics for infectious diseases and cancer [2] - The company has developed a proprietary PIKA® immunomodulating technology platform targeting various viral infections [2] - LakeShore Biopharma operates in multiple countries including China, the United States, Singapore, and the Philippines [2]
YS Biopharma Announces Name Change to LakeShore Biopharma